GARDP webinar: Clinical development for non-developers Part 3: Antibacterial Drug Enhancer Combinations and Non-traditional Products
28 March, 17:00-18:30 CET
Registration link here
The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products.
The presentations will be followed by a Q&A session.
Ian Friedland, Clinical consultant, Friedland Strategic Consulting, LLC
Sumathi Nambiar, Director, Division of Anti-Infective Products, Office of Antimicrobial Products, CDER, FDA (US)
Mair Powell, Senior clinical assessor, Health Products Regulatory Authority (Ireland)
Moderator: David Shlaes, Anti-infectives consulting, retired